Clinical Trials Directory

Trials / Completed

CompletedNCT05396677

The Effects of Acetaminophen on Fear

Behavioral Consequences of Blunting Fear With Acetaminophen

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
266 (actual)
Sponsor
University of Guelph · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study investigates the effects of acetaminophen on behavioral, physiological, and self-report fear responses.

Detailed description

As acetaminophen blunts the experience of physical, social, and empathic pain, it is important to investigate whether there are other aversive states that the drug also provides relief from. If there are others, this may suggest overlapping mechanisms involved in these affective evaluations, all of which are interrupted by acetaminophen. The emotion of fear is aversive, yet it is distinct from both physical and social pain. The present study will investigate the effects of acetaminophen on the subjective experience of fear as well as its behavioral outcomes. While blocking adaptive behavioral responses to fear could potentially be problematic in some dangerous situations, it may also be helpful for those with anxiety-related disorders. If individuals on acetaminophen can step farther away from safety on a virtual plank 80 stories above the ground, then perhaps acetaminophen can allow anxious individuals to step farther from their comfort zone in real life. Importantly, if acetaminophen blunts the fear response, this would mean that the drug blocks aversive feelings beyond emotional and physical pain. The extent of its effects will warrant further investigation for a greater understanding of emotional evaluations.

Conditions

Interventions

TypeNameDescription
DRUGAcetaminophen2 x 500 mg acetaminophen (one time)
OTHERPlacebo2 x 500 mg microcrystalline cellulose (one time)

Timeline

Start date
2022-03-30
Primary completion
2023-06-12
Completion
2023-06-12
First posted
2022-05-31
Last updated
2024-09-23

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05396677. Inclusion in this directory is not an endorsement.